APO Research
Talk to an analyst

APO RESEARCH · REPORT

Flu (Influenza) Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Flu (Influenza) Vaccine Market Analysis and Forecast 2026-2032

2 January 2026190 pages

Choose your research edition.

Industry ResearchFlu (Influenza) Vaccine Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Flu (Influenza) Vaccine Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Flu (Influenza) Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Flu (Influenza) Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Flu (Influenza) Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Flu (Influenza) Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Flu (Influenza) Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Flu (Influenza) Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Flu (Influenza) Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Flu (Influenza) Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Flu (Influenza) Vaccine include Adimmune, Aimei Hissen, Aleph Biomedical, CCBIO, Changsheng Biological, Hualan Bio, Simcere Vaxtec, SINOVAC and SIOBP, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Flu (Influenza) Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Flu (Influenza) Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Flu (Influenza) Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Flu (Influenza) Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Flu (Influenza) Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Flu (Influenza) Vaccine sales, projected growth trends, production technology, application and end-user industry.

Flu (Influenza) Vaccine Segment by Company

Adimmune

Aimei Hissen

Aleph Biomedical

CCBIO

Changsheng Biological

Hualan Bio

Simcere Vaxtec

SINOVAC

SIOBP

Tianyuan Bio-pharma(Novartis)

ZYAK

GSK

SANOFI

Flu (Influenza) Vaccine Segment by Type

Subunit Influenza Vaccine

Quadrivalent Influenza Vaccine

Split Influenza Vaccine

Pandemic Influenza Vaccine

Flu (Influenza) Vaccine Segment by Application

For Children (6 months to 3 years)

For Adults and Children over 3 years

Flu (Influenza) Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flu (Influenza) Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Flu (Influenza) Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flu (Influenza) Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Flu (Influenza) Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Flu (Influenza) Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Flu (Influenza) Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Flu (Influenza) Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Subunit Influenza Vaccine Major Manufacturers Table 3. Quadrivalent Influenza Vaccine Major Manufacturers Table 4. Split Influenza Vaccine Major Manufacturers Table 5. Pandemic Influenza Vaccine Major Manufacturers Table 6. Global Flu (Influenza) Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. For Children (6 months to 3 years) Major Manufacturers Table 8. For Adults and Children over 3 years Major Manufacturers Table 9. Flu (Influenza) Vaccine Industry Trends Table 10. Flu (Influenza) Vaccine Industry Drivers Table 11. Flu (Influenza) Vaccine Industry Opportunities and Challenges Table 12. Flu (Influenza) Vaccine Industry Restraints Table 13. Global Flu (Influenza) Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Flu (Influenza) Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Flu (Influenza) Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Flu (Influenza) Vaccine Revenue Market Share by Region (2021-2026) Table 17. Global Flu (Influenza) Vaccine Revenue Market Share by Region (2027-2032) Table 18. Global Flu (Influenza) Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Flu (Influenza) Vaccine Sales by Region (2021-2026) & (K Units) Table 20. Global Flu (Influenza) Vaccine Sales by Region (2027-2032) & (K Units) Table 21. Global Flu (Influenza) Vaccine Sales Market Share by Region (2021-2026) Table 22. Global Flu (Influenza) Vaccine Sales Market Share by Region (2027-2032) Table 23. Global Flu (Influenza) Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Flu (Influenza) Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Flu (Influenza) Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Flu (Influenza) Vaccine Sales Market Share by Manufacturers (2021-2026) Table 27. Global Flu (Influenza) Vaccine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Flu (Influenza) Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Flu (Influenza) Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Flu (Influenza) Vaccine Manufacturers, Product Type & Application Table 31. Global Flu (Influenza) Vaccine Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Flu (Influenza) Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Flu (Influenza) Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Flu (Influenza) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Flu (Influenza) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Flu (Influenza) Vaccine Revenue Market Share by Type (2021-2026) Table 38. Global Flu (Influenza) Vaccine Revenue Market Share by Type (2027-2032) Table 39. Global Flu (Influenza) Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Flu (Influenza) Vaccine Sales by Type (2021-2026) & (K Units) Table 41. Global Flu (Influenza) Vaccine Sales by Type (2027-2032) & (K Units) Table 42. Global Flu (Influenza) Vaccine Sales Market Share by Type (2021-2026) Table 43. Global Flu (Influenza) Vaccine Sales Market Share by Type (2027-2032) Table 44. Global Flu (Influenza) Vaccine Price by Type (2021-2026) & (US$/Unit) Table 45. Global Flu (Influenza) Vaccine Price by Type (2027-2032) & (US$/Unit) Table 46. Global Flu (Influenza) Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Flu (Influenza) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Flu (Influenza) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Flu (Influenza) Vaccine Revenue Market Share by Application (2021-2026) Table 50. Global Flu (Influenza) Vaccine Revenue Market Share by Application (2027-2032) Table 51. Global Flu (Influenza) Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Flu (Influenza) Vaccine Sales by Application (2021-2026) & (K Units) Table 53. Global Flu (Influenza) Vaccine Sales by Application (2027-2032) & (K Units) Table 54. Global Flu (Influenza) Vaccine Sales Market Share by Application (2021-2026) Table 55. Global Flu (Influenza) Vaccine Sales Market Share by Application (2027-2032) Table 56. Global Flu (Influenza) Vaccine Price by Application (2021-2026) & (US$/Unit) Table 57. Global Flu (Influenza) Vaccine Price by Application (2027-2032) & (US$/Unit) Table 58. Adimmune Company Information Table 59. Adimmune Business Overview Table 60. Adimmune Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Adimmune Flu (Influenza) Vaccine Product Portfolio Table 62. Adimmune Recent Development Table 63. Aimei Hissen Company Information Table 64. Aimei Hissen Business Overview Table 65. Aimei Hissen Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Aimei Hissen Flu (Influenza) Vaccine Product Portfolio Table 67. Aimei Hissen Recent Development Table 68. Aleph Biomedical Company Information Table 69. Aleph Biomedical Business Overview Table 70. Aleph Biomedical Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Aleph Biomedical Flu (Influenza) Vaccine Product Portfolio Table 72. Aleph Biomedical Recent Development Table 73. CCBIO Company Information Table 74. CCBIO Business Overview Table 75. CCBIO Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. CCBIO Flu (Influenza) Vaccine Product Portfolio Table 77. CCBIO Recent Development Table 78. Changsheng Biological Company Information Table 79. Changsheng Biological Business Overview Table 80. Changsheng Biological Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Changsheng Biological Flu (Influenza) Vaccine Product Portfolio Table 82. Changsheng Biological Recent Development Table 83. Hualan Bio Company Information Table 84. Hualan Bio Business Overview Table 85. Hualan Bio Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Hualan Bio Flu (Influenza) Vaccine Product Portfolio Table 87. Hualan Bio Recent Development Table 88. Simcere Vaxtec Company Information Table 89. Simcere Vaxtec Business Overview Table 90. Simcere Vaxtec Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Simcere Vaxtec Flu (Influenza) Vaccine Product Portfolio Table 92. Simcere Vaxtec Recent Development Table 93. SINOVAC Company Information Table 94. SINOVAC Business Overview Table 95. SINOVAC Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. SINOVAC Flu (Influenza) Vaccine Product Portfolio Table 97. SINOVAC Recent Development Table 98. SIOBP Company Information Table 99. SIOBP Business Overview Table 100. SIOBP Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. SIOBP Flu (Influenza) Vaccine Product Portfolio Table 102. SIOBP Recent Development Table 103. Tianyuan Bio-pharma(Novartis) Company Information Table 104. Tianyuan Bio-pharma(Novartis) Business Overview Table 105. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Product Portfolio Table 107. Tianyuan Bio-pharma(Novartis) Recent Development Table 108. ZYAK Company Information Table 109. ZYAK Business Overview Table 110. ZYAK Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. ZYAK Flu (Influenza) Vaccine Product Portfolio Table 112. ZYAK Recent Development Table 113. GSK Company Information Table 114. GSK Business Overview Table 115. GSK Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. GSK Flu (Influenza) Vaccine Product Portfolio Table 117. GSK Recent Development Table 118. SANOFI Company Information Table 119. SANOFI Business Overview Table 120. SANOFI Flu (Influenza) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. SANOFI Flu (Influenza) Vaccine Product Portfolio Table 122. SANOFI Recent Development Table 123. North America Flu (Influenza) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 124. North America Flu (Influenza) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 125. North America Flu (Influenza) Vaccine Sales by Type (2021-2026) & (K Units) Table 126. North America Flu (Influenza) Vaccine Sales by Type (2027-2032) & (K Units) Table 127. North America Flu (Influenza) Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 128. North America Flu (Influenza) Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 129. North America Flu (Influenza) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 130. North America Flu (Influenza) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 131. North America Flu (Influenza) Vaccine Sales by Application (2021-2026) & (K Units) Table 132. North America Flu (Influenza) Vaccine Sales by Application (2027-2032) & (K Units) Table 133. North America Flu (Influenza) Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 134. North America Flu (Influenza) Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 135. North America Flu (Influenza) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. North America Flu (Influenza) Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 137. North America Flu (Influenza) Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 138. North America Flu (Influenza) Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 139. North America Flu (Influenza) Vaccine Sales by Country (2021-2026) & (K Units) Table 140. North America Flu (Influenza) Vaccine Sales by Country (2027-2032) & (K Units) Table 141. North America Flu (Influenza) Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 142. North America Flu (Influenza) Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 143. United States Flu (Influenza) Vaccine Revenue (2021-2032) & (US$ Million) Table 144. Canada Flu (Influenza) Vaccine Revenue (2021-2032) & (US$ Million) Table 145. Europe Flu (Influenza) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 146. Europe Flu (Influenza) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 147. Europe Flu (Influenza) Vaccine Sales by Type (2021-2026) & (K Units) Table 148. Europe Flu (Influenza) Vaccine Sales by Type (2027-2032) & (K Units) Table 149. Europe Flu (Influenza) Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 150. Europe Flu (Influenza) Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 151. Europe Flu (Influenza) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 152. Europe Flu (Influenza) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 153. Europe Flu (Influenza) Vaccine Sales by Application (2021-2026) & (K Units) Table 154. Europe Flu (Influenza) Vaccine Sales by Application (2027-2032) & (K Units) Table 155. Europe Flu (Influenza) Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 156. Europe Flu (Influenza) Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 157. Europe Flu (Influenza) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. Europe Flu (Influenza) Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 159. Europe Flu (Influenza) Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 160. Europe Flu (Influenza) Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 161. Europe Flu (Influenza) Vaccine Sales by Country (2021-2026) & (K Units) Table 162. Europe Flu (Influenza) Vaccine Sales by Country (2027-2032) & (K Units) Table 163. Europe Flu (Influenza) Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 164. Europe Flu (Influenza) Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 165. Germany Flu (Influenza) Vaccine Revenue (2021-2032) & (US$ Million) Table 166. France Flu (Influenza) Vaccine Revenue (2021-2032) & (US$ Million) Table 167. U.K. Flu (Influenza) Vaccine Revenue (2021-2032) & (US$ Million) Table 168. Italy Flu (Influenza) Vaccine Revenue (2021-2032) & (US$ Million) Table 169. Netherlands Flu (Influenza) Vaccine Revenue (2021-2032) & (US$ Million) Table 170. China Flu (Influenza) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 171. China Flu (Influenza) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 172. China Flu (Influenza) Vaccine Sales by Type (2021-2026) & (K Units) Table 173. China Flu (Influenza) Vaccine Sales by Type (2027-2032) & (K Units) Table 174. China Flu (Influenza) Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 175. China Flu (Influenza) Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 176. China Flu (Influenza) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 177. China Flu (Influenza) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 178. China Flu (Influenza) Vaccine Sales by Application (2021-2026) & (K Units) Table 179. China Flu (Influenza) Vaccine Sales by Application (2027-2032) & (K Units) Table 180. China Flu (Influenza) Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 181. China Flu (Influenza) Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 182. Asia Flu (Influenza) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 183. Asia Flu (Influenza) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 184. Asia Flu (Influenza) Vaccine Sales by Type (2021-2026) & (K Units) Table 185. Asia Flu (Influenza) Vaccine Sales by Type (2027-2032) & (K Units) Table 186. Asia Flu (Influenza) Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 187. Asia Flu (Influenza) Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 188. Asia Flu (Influenza) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 189. Asia Flu (Influenza) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 190. Asia Flu (Influenza) Vaccine Sales by Application (2021-2026) & (K Units) Table 191. Asia Flu (Influenza) Vaccine Sales by Application (2027-2032) & (K Units) Table 192. Asia Flu (Influenza) Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 193. Asia Flu (Influenza) Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 194. Asia Flu (Influenza) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. Asia Flu (Influenza) Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. Asia Flu (Influenza) Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. Asia Flu (Influenza) Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 198. Asia Flu (Influenza) Vaccine Sales by Country (2021-2026) & (K Units) Table 199. Asia Flu (Influenza) Vaccine Sales by Country (2027-2032) & (K Units) Table 200. Asia Flu (Influenza) Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 201. Asia Flu (Influenza) Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 202. Japan Flu (Influenza) Vaccine Revenue (2021-2032) & (US$ Million) Table 203. South Korea Flu (Influenza) Vaccine Revenue (2021-2032) & (US$ Million) Table 204. India Flu (Influenza) Vaccine Revenue (2021-2032) & (US$ Million) Table 205. Australia Flu (Influenza) Vaccine Revenue (2021-2032) & (US$ Million) Table 206. China Taiwan Flu (Influenza) Vaccine Revenue (2021-2032) & (US$ Million) Table 207. Southeast Asia Flu (Influenza) Vaccine Revenue (2021-2032) & (US$ Million) Table 208. SAMEA Flu (Influenza) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 209. SAMEA Flu (Influenza) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 210. SAMEA Flu (Influenza) Vaccine Sales by Type (2021-2026) & (K Units) Table 211. SAMEA Flu (Influenza) Vaccine Sales by Type (2027-2032) & (K Units) Table 212. SAMEA Flu (Influenza) Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 213. SAMEA Flu (Influenza) Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 214. SAMEA Flu (Influenza) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 215. SAMEA Flu (Influenza) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 216. SAMEA Flu (Influenza) Vaccine Sales by Application (2021-2026) & (K Units) Table 217. SAMEA Flu (Influenza) Vaccine Sales by Application (2027-2032) & (K Units) Table 218. SAMEA Flu (Influenza) Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 219. SAMEA Flu (Influenza) Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 220. SAMEA Flu (Influenza) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 221. SAMEA Flu (Influenza) Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 222. SAMEA Flu (Influenza) Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 223. SAMEA Flu (Influenza) Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 224. SAMEA Flu (Influenza) Vaccine Sales by Country (2021-2026) & (K Units) Table 225. SAMEA Flu (Influenza) Vaccine Sales by Country (2027-2032) & (K Units) Table 226. SAMEA Flu (Influenza) Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 227. SAMEA Flu (Influenza) Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 228. Brazil Flu (Influenza) Vaccine Revenue (2021-2032) & (US$ Million) Table 229. Argentina Flu (Influenza) Vaccine Revenue (2021-2032) & (US$ Million) Table 230. Chile Flu (Influenza) Vaccine Revenue (2021-2032) & (US$ Million) Table 231. Colombia Flu (Influenza) Vaccine Revenue (2021-2032) & (US$ Million) Table 232. Peru Flu (Influenza) Vaccine Revenue (2021-2032) & (US$ Million) Table 233. Saudi Arabia Flu (Influenza) Vaccine Revenue (2021-2032) & (US$ Million) Table 234. Israel Flu (Influenza) Vaccine Revenue (2021-2032) & (US$ Million) Table 235. UAE Flu (Influenza) Vaccine Revenue (2021-2032) & (US$ Million) Table 236. Turkey Flu (Influenza) Vaccine Revenue (2021-2032) & (US$ Million) Table 237. Iran Flu (Influenza) Vaccine Revenue (2021-2032) & (US$ Million) Table 238. Egypt Flu (Influenza) Vaccine Revenue (2021-2032) & (US$ Million) Table 239. Key Raw Materials Table 240. Raw Materials Key Suppliers Table 241. Flu (Influenza) Vaccine Distributors List Table 242. Flu (Influenza) Vaccine Customers List Table 243. Research Programs/Design for This Report Table 244. Authors List of This Report Table 245. Secondary Sources Table 246. Primary Sources List of Figures Figure 1. Flu (Influenza) Vaccine Image Figure 2. Global Flu (Influenza) Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Flu (Influenza) Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Subunit Influenza Vaccine Image Figure 5. Quadrivalent Influenza Vaccine Image Figure 6. Split Influenza Vaccine Image Figure 7. Pandemic Influenza Vaccine Image Figure 8. Global Flu (Influenza) Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Flu (Influenza) Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 10. For Children (6 months to 3 years) Image Figure 11. For Adults and Children over 3 years Image Figure 12. Global Flu (Influenza) Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Flu (Influenza) Vaccine Revenue (2021-2032) & (US$ Million) Figure 14. Global Flu (Influenza) Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Flu (Influenza) Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Flu (Influenza) Vaccine Revenue Market Share by Region (2021-2032) Figure 17. Global Flu (Influenza) Vaccine Sales (2021-2032) & (K Units) Figure 18. Global Flu (Influenza) Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Flu (Influenza) Vaccine Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Flu (Influenza) Vaccine Sales YoY (2021-2032) & (K Units) Figure 21. Europe Flu (Influenza) Vaccine Sales YoY (2021-2032) & (K Units) Figure 22. China Flu (Influenza) Vaccine Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Flu (Influenza) Vaccine Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Flu (Influenza) Vaccine Sales YoY (2021-2032) & (K Units) Figure 25. Global Flu (Influenza) Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Flu (Influenza) Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Flu (Influenza) Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Flu (Influenza) Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Flu (Influenza) Vaccine Revenue Market Share by Type (2021-2032) Figure 31. Global Flu (Influenza) Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Flu (Influenza) Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Flu (Influenza) Vaccine Sales Market Share by Type (2021-2032) Figure 34. Global Flu (Influenza) Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Flu (Influenza) Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Flu (Influenza) Vaccine Revenue Market Share by Application (2021-2032) Figure 37. Global Flu (Influenza) Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Flu (Influenza) Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Flu (Influenza) Vaccine Sales Market Share by Application (2021-2032) Figure 40. North America Flu (Influenza) Vaccine Revenue Share by Type (2021-2032) Figure 41. North America Flu (Influenza) Vaccine Sales Share by Type (2021-2032) Figure 42. North America Flu (Influenza) Vaccine Revenue Share by Application (2021-2032) Figure 43. North America Flu (Influenza) Vaccine Sales Share by Application (2021-2032) Figure 44. North America Flu (Influenza) Vaccine Revenue Share by Country (2021-2032) Figure 45. North America Flu (Influenza) Vaccine Sales Share by Country (2021-2032) Figure 46. Europe Flu (Influenza) Vaccine Revenue Share by Type (2021-2032) Figure 47. Europe Flu (Influenza) Vaccine Sales Share by Type (2021-2032) Figure 48. Europe Flu (Influenza) Vaccine Revenue Share by Application (2021-2032) Figure 49. Europe Flu (Influenza) Vaccine Sales Share by Application (2021-2032) Figure 50. Europe Flu (Influenza) Vaccine Revenue Share by Country (2021-2032) Figure 51. Europe Flu (Influenza) Vaccine Sales Share by Country (2021-2032) Figure 52. China Flu (Influenza) Vaccine Revenue Share by Type (2021-2032) Figure 53. China Flu (Influenza) Vaccine Sales Share by Type (2021-2032) Figure 54. China Flu (Influenza) Vaccine Revenue Share by Application (2021-2032) Figure 55. China Flu (Influenza) Vaccine Sales Share by Application (2021-2032) Figure 56. Asia Flu (Influenza) Vaccine Revenue Share by Type (2021-2032) Figure 57. Asia Flu (Influenza) Vaccine Sales Share by Type (2021-2032) Figure 58. Asia Flu (Influenza) Vaccine Revenue Share by Application (2021-2032) Figure 59. Asia Flu (Influenza) Vaccine Sales Share by Application (2021-2032) Figure 60. Asia Flu (Influenza) Vaccine Revenue Share by Country (2021-2032) Figure 61. Asia Flu (Influenza) Vaccine Sales Share by Country (2021-2032) Figure 62. SAMEA Flu (Influenza) Vaccine Revenue Share by Type (2021-2032) Figure 63. SAMEA Flu (Influenza) Vaccine Sales Share by Type (2021-2032) Figure 64. SAMEA Flu (Influenza) Vaccine Revenue Share by Application (2021-2032) Figure 65. SAMEA Flu (Influenza) Vaccine Sales Share by Application (2021-2032) Figure 66. SAMEA Flu (Influenza) Vaccine Revenue Share by Country (2021-2032) Figure 67. SAMEA Flu (Influenza) Vaccine Sales Share by Country (2021-2032) Figure 68. Flu (Influenza) Vaccine Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Flu (Influenza) Vaccine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Subunit Influenza Vaccine
  • Quadrivalent Influenza Vaccine
  • Split Influenza Vaccine
  • Pandemic Influenza Vaccine
Applications
  • For Children (6 months to 3 years)
  • For Adults and Children over 3 years
Companies covered
  • Adimmune
  • Aimei Hissen
  • Aleph Biomedical
  • CCBIO
  • Changsheng Biological
  • Hualan Bio
  • Simcere Vaxtec
  • SINOVAC
  • SIOBP
  • Tianyuan Bio-pharma(Novartis)
  • ZYAK
  • GSK
  • SANOFI

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Flu (Influenza) Vaccine Market by Type
  3. 1.2.1 Global Flu (Influenza) Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Subunit Influenza Vaccine
  5. 1.2.3 Quadrivalent Influenza Vaccine
  6. 1.2.4 Split Influenza Vaccine
  7. 1.2.5 Pandemic Influenza Vaccine
  8. 1.3 Flu (Influenza) Vaccine Market by Application
  9. 1.3.1 Global Flu (Influenza) Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 For Children (6 months to 3 years)
  11. 1.3.3 For Adults and Children over 3 years
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Flu (Influenza) Vaccine Market Dynamics
  1. 2.1 Flu (Influenza) Vaccine Industry Trends
  2. 2.2 Flu (Influenza) Vaccine Industry Drivers
  3. 2.3 Flu (Influenza) Vaccine Industry Opportunities and Challenges
  4. 2.4 Flu (Influenza) Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Flu (Influenza) Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Flu (Influenza) Vaccine Revenue by Region
  3. 3.2.1 Global Flu (Influenza) Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Flu (Influenza) Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Flu (Influenza) Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Flu (Influenza) Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Flu (Influenza) Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Flu (Influenza) Vaccine Sales by Region
  9. 3.4.1 Global Flu (Influenza) Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Flu (Influenza) Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Flu (Influenza) Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Flu (Influenza) Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Flu (Influenza) Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Flu (Influenza) Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Flu (Influenza) Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Flu (Influenza) Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Flu (Influenza) Vaccine Sales by Manufacturers
  6. 4.2.1 Global Flu (Influenza) Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Flu (Influenza) Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Flu (Influenza) Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Flu (Influenza) Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Flu (Influenza) Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Flu (Influenza) Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Flu (Influenza) Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Flu (Influenza) Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Flu (Influenza) Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Flu (Influenza) Vaccine Tier 1, Tier 2, and Tier 3
5 Flu (Influenza) Vaccine Market by Type
  1. 5.1 Global Flu (Influenza) Vaccine Revenue by Type
  2. 5.1.1 Global Flu (Influenza) Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Flu (Influenza) Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Flu (Influenza) Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Flu (Influenza) Vaccine Sales by Type
  6. 5.2.1 Global Flu (Influenza) Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Flu (Influenza) Vaccine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Flu (Influenza) Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Flu (Influenza) Vaccine Price by Type
6 Flu (Influenza) Vaccine Market by Application
  1. 6.1 Global Flu (Influenza) Vaccine Revenue by Application
  2. 6.1.1 Global Flu (Influenza) Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Flu (Influenza) Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Flu (Influenza) Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Flu (Influenza) Vaccine Sales by Application
  6. 6.2.1 Global Flu (Influenza) Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Flu (Influenza) Vaccine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Flu (Influenza) Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Flu (Influenza) Vaccine Price by Application
7 Company Profiles
  1. 7.1 Adimmune
  2. 7.1.1 Adimmune Company Information
  3. 7.1.2 Adimmune Business Overview
  4. 7.1.3 Adimmune Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Adimmune Flu (Influenza) Vaccine Product Portfolio
  6. 7.1.5 Adimmune Recent Developments
  7. 7.2 Aimei Hissen
  8. 7.2.1 Aimei Hissen Company Information
  9. 7.2.2 Aimei Hissen Business Overview
  10. 7.2.3 Aimei Hissen Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Aimei Hissen Flu (Influenza) Vaccine Product Portfolio
  12. 7.2.5 Aimei Hissen Recent Developments
  13. 7.3 Aleph Biomedical
  14. 7.3.1 Aleph Biomedical Company Information
  15. 7.3.2 Aleph Biomedical Business Overview
  16. 7.3.3 Aleph Biomedical Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Aleph Biomedical Flu (Influenza) Vaccine Product Portfolio
  18. 7.3.5 Aleph Biomedical Recent Developments
  19. 7.4 CCBIO
  20. 7.4.1 CCBIO Company Information
  21. 7.4.2 CCBIO Business Overview
  22. 7.4.3 CCBIO Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 CCBIO Flu (Influenza) Vaccine Product Portfolio
  24. 7.4.5 CCBIO Recent Developments
  25. 7.5 Changsheng Biological
  26. 7.5.1 Changsheng Biological Company Information
  27. 7.5.2 Changsheng Biological Business Overview
  28. 7.5.3 Changsheng Biological Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Changsheng Biological Flu (Influenza) Vaccine Product Portfolio
  30. 7.5.5 Changsheng Biological Recent Developments
  31. 7.6 Hualan Bio
  32. 7.6.1 Hualan Bio Company Information
  33. 7.6.2 Hualan Bio Business Overview
  34. 7.6.3 Hualan Bio Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Hualan Bio Flu (Influenza) Vaccine Product Portfolio
  36. 7.6.5 Hualan Bio Recent Developments
  37. 7.7 Simcere Vaxtec
  38. 7.7.1 Simcere Vaxtec Company Information
  39. 7.7.2 Simcere Vaxtec Business Overview
  40. 7.7.3 Simcere Vaxtec Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Simcere Vaxtec Flu (Influenza) Vaccine Product Portfolio
  42. 7.7.5 Simcere Vaxtec Recent Developments
  43. 7.8 SINOVAC
  44. 7.8.1 SINOVAC Company Information
  45. 7.8.2 SINOVAC Business Overview
  46. 7.8.3 SINOVAC Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 SINOVAC Flu (Influenza) Vaccine Product Portfolio
  48. 7.8.5 SINOVAC Recent Developments
  49. 7.9 SIOBP
  50. 7.9.1 SIOBP Company Information
  51. 7.9.2 SIOBP Business Overview
  52. 7.9.3 SIOBP Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 SIOBP Flu (Influenza) Vaccine Product Portfolio
  54. 7.9.5 SIOBP Recent Developments
  55. 7.10 Tianyuan Bio-pharma(Novartis)
  56. 7.10.1 Tianyuan Bio-pharma(Novartis) Company Information
  57. 7.10.2 Tianyuan Bio-pharma(Novartis) Business Overview
  58. 7.10.3 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Product Portfolio
  60. 7.10.5 Tianyuan Bio-pharma(Novartis) Recent Developments
  61. 7.11 ZYAK
  62. 7.11.1 ZYAK Company Information
  63. 7.11.2 ZYAK Business Overview
  64. 7.11.3 ZYAK Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 ZYAK Flu (Influenza) Vaccine Product Portfolio
  66. 7.11.5 ZYAK Recent Developments
  67. 7.12 GSK
  68. 7.12.1 GSK Company Information
  69. 7.12.2 GSK Business Overview
  70. 7.12.3 GSK Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 GSK Flu (Influenza) Vaccine Product Portfolio
  72. 7.12.5 GSK Recent Developments
  73. 7.13 SANOFI
  74. 7.13.1 SANOFI Company Information
  75. 7.13.2 SANOFI Business Overview
  76. 7.13.3 SANOFI Flu (Influenza) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 SANOFI Flu (Influenza) Vaccine Product Portfolio
  78. 7.13.5 SANOFI Recent Developments
8 North America
  1. 8.1 North America Flu (Influenza) Vaccine Market Size by Type
  2. 8.1.1 North America Flu (Influenza) Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Flu (Influenza) Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Flu (Influenza) Vaccine Price by Type (2021-2032)
  5. 8.2 North America Flu (Influenza) Vaccine Market Size by Application
  6. 8.2.1 North America Flu (Influenza) Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Flu (Influenza) Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Flu (Influenza) Vaccine Price by Application (2021-2032)
  9. 8.3 North America Flu (Influenza) Vaccine Market Size by Country
  10. 8.3.1 North America Flu (Influenza) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Flu (Influenza) Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Flu (Influenza) Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Flu (Influenza) Vaccine Market Size by Type
  2. 9.1.1 Europe Flu (Influenza) Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Flu (Influenza) Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Flu (Influenza) Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Flu (Influenza) Vaccine Market Size by Application
  6. 9.2.1 Europe Flu (Influenza) Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Flu (Influenza) Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Flu (Influenza) Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Flu (Influenza) Vaccine Market Size by Country
  10. 9.3.1 Europe Flu (Influenza) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Flu (Influenza) Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Flu (Influenza) Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Flu (Influenza) Vaccine Market Size by Type
  2. 10.1.1 China Flu (Influenza) Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Flu (Influenza) Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Flu (Influenza) Vaccine Price by Type (2021-2032)
  5. 10.2 China Flu (Influenza) Vaccine Market Size by Application
  6. 10.2.1 China Flu (Influenza) Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Flu (Influenza) Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Flu (Influenza) Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Flu (Influenza) Vaccine Market Size by Type
  2. 11.1.1 Asia Flu (Influenza) Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Flu (Influenza) Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Flu (Influenza) Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Flu (Influenza) Vaccine Market Size by Application
  6. 11.2.1 Asia Flu (Influenza) Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Flu (Influenza) Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Flu (Influenza) Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Flu (Influenza) Vaccine Market Size by Country
  10. 11.3.1 Asia Flu (Influenza) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Flu (Influenza) Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Flu (Influenza) Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Flu (Influenza) Vaccine Market Size by Type
  2. 12.1.1 SAMEA Flu (Influenza) Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Flu (Influenza) Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Flu (Influenza) Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Flu (Influenza) Vaccine Market Size by Application
  6. 12.2.1 SAMEA Flu (Influenza) Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Flu (Influenza) Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Flu (Influenza) Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Flu (Influenza) Vaccine Market Size by Country
  10. 12.3.1 SAMEA Flu (Influenza) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Flu (Influenza) Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Flu (Influenza) Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Flu (Influenza) Vaccine Value Chain Analysis
  2. 13.1.1 Flu (Influenza) Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Flu (Influenza) Vaccine Production Mode & Process
  6. 13.2 Flu (Influenza) Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Flu (Influenza) Vaccine Distributors
  9. 13.2.3 Flu (Influenza) Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst